| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $640.9M | -2.6% |
| Cost of Revenue | $511.8M | -1.9% |
| Gross Profit | $129.1M | -5.4% |
| R&D Expense | $11.8M | +37.2% |
| SG&A Expense | $90.1M | -14.0% |
| Operating Income | $38.8M | +23.0% |
| Interest Expense | $4.6M | +60.8% |
| Pre-tax Income | $32.4M | +12.0% |
| Income Tax | $7.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $928K | -17.5% |
| Inventory | $156.0M | -14.9% |
| Current Assets | $284.7M | -10.6% |
| Total Assets | $388.9M | +1.7% |
| Current Liabilities | $101.6M | -38.1% |
| Total Liabilities | $264.4M | -5.6% |
| Stockholders' Equity | $124.5M | +21.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $2.3M | -80.8% |
| Financing Cash Flow | $5.6M | +176.7% |
| -6.4% |
| Net Income | $25.3M | +18.6% |
| EPS (Basic) | $1.81 | +17.5% |
| EPS (Diluted) | $1.81 | +18.3% |